PortfoliosLab logoPortfoliosLab logo
LCUT vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LCUT vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lifetime Brands, Inc. (LCUT) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LCUT achieves a 141.74% return, which is significantly higher than NVO's -11.01% return. Over the past 10 years, LCUT has underperformed NVO with an annualized return of -2.96%, while NVO has yielded a comparatively higher 6.56% annualized return.


LCUT

1D
0.43%
1M
45.27%
YTD
141.74%
6M
123.62%
1Y
187.17%
3Y*
27.45%
5Y*
-8.45%
10Y*
-2.96%

NVO

1D
4.17%
1M
-2.50%
YTD
-11.01%
6M
-5.65%
1Y
-36.44%
3Y*
-15.71%
5Y*
3.74%
10Y*
6.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LCUT vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LCUT
Lifetime Brands, Inc.
141.74%-30.37%-9.95%-8.95%-51.76%6.23%123.08%-29.39%-38.37%-6.17%
NVO
Novo Nordisk A/S
-11.01%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between LCUT and NVO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Jun 6, 1991

0.10

Fundamentals

EPS

LCUT:

-$1.69

NVO:

$27.42

PS Ratio

LCUT:

0.23

NVO:

0.59

Total Revenue (TTM)

LCUT:

$651.36M

NVO:

$327.80B

Gross Profit (TTM)

LCUT:

$244.23M

NVO:

$268.30B

EBITDA (TTM)

LCUT:

$3.18M

NVO:

$181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LCUT vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LCUT
LCUT Risk / Return Rank: 8787
Overall Rank
LCUT Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
LCUT Sortino Ratio Rank: 8888
Sortino Ratio Rank
LCUT Omega Ratio Rank: 8484
Omega Ratio Rank
LCUT Calmar Ratio Rank: 8989
Calmar Ratio Rank
LCUT Martin Ratio Rank: 8282
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1616
Overall Rank
NVO Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1515
Sortino Ratio Rank
NVO Omega Ratio Rank: 1313
Omega Ratio Rank
NVO Calmar Ratio Rank: 1818
Calmar Ratio Rank
NVO Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LCUT vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lifetime Brands, Inc. (LCUT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LCUTNVODifference
Sharpe ratioReturn per unit of total volatility

+2.87

Sortino ratioReturn per unit of downside risk

+3.78

Omega ratioGain probability vs. loss probability

1.35

0.89

+0.46

Calmar ratioReturn relative to maximum drawdown

4.29

-0.66

+4.96

Martin ratioReturn relative to average drawdown

7.42

-0.99

+8.41

LCUT vs. NVO - Sharpe Ratio Comparison

The current LCUT Sharpe Ratio is 2.16, which is higher than the NVO Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of LCUT and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LCUTNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.16

-0.70

+2.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.13

0.10

-0.23

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.05

0.20

-0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

0.04

0.47

-0.43

Drawdowns

LCUT vs. NVO - Drawdown Comparison

The maximum LCUT drawdown since its inception was -96.52%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for LCUT and NVO.


Loading charts...

Drawdown Indicators


LCUTNVODifference

Max Drawdown

Largest peak-to-trough decline

-96.52%

-74.70%

-21.82%

Max Drawdown (1Y)

Largest decline over 1 year

-43.88%

-55.03%

+11.15%

Max Drawdown (3Y)

Largest decline over 3 years

-73.35%

-74.70%

+1.35%

Max Drawdown (5Y)

Largest decline over 5 years

-83.39%

-74.70%

-8.69%

Max Drawdown (10Y)

Largest decline over 10 years

-83.39%

-74.70%

-8.69%

Current Drawdown

Current decline from peak

-57.59%

-68.21%

+10.62%

Average Drawdown

Average peak-to-trough decline

-43.71%

-17.76%

-25.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.33%

36.98%

-11.65%

Volatility

LCUT vs. NVO - Volatility Comparison

Lifetime Brands, Inc. (LCUT) has a higher volatility of 43.13% compared to Novo Nordisk A/S (NVO) at 8.89%. This indicates that LCUT's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LCUTNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

43.13%

8.89%

+34.24%

Volatility (6M)

Calculated over the trailing 6-month period

68.74%

38.00%

+30.74%

Volatility (1Y)

Calculated over the trailing 1-year period

87.30%

51.88%

+35.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

63.24%

38.25%

+24.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.47%

32.51%

+26.96%

Dividends

LCUT vs. NVO - Dividend Comparison

LCUT's dividend yield for the trailing twelve months is around 1.81%, less than NVO's 4.12% yield.


PositionTTM20252024202320222021202020192018201720162015
LCUT
Lifetime Brands, Inc.
1.81%4.30%2.88%2.53%2.24%1.06%1.12%2.45%1.69%1.03%0.96%1.17%
NVO
Novo Nordisk A/S
4.12%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

LCUT vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Lifetime Brands, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
143.51M
96.82B
(LCUT) Total Revenue
(NVO) Total Revenue
Values in USD except per share items

LCUT vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Lifetime Brands, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
37.8%
86.0%
Portfolio components
LCUT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lifetime Brands, Inc. reported a gross profit of 54.17M and revenue of 143.51M. Therefore, the gross margin over that period was 37.8%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

LCUT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lifetime Brands, Inc. reported an operating income of -2.23M and revenue of 143.51M, resulting in an operating margin of -1.6%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

LCUT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lifetime Brands, Inc. reported a net income of -4.77M and revenue of 143.51M, resulting in a net margin of -3.3%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


LCUT and NVO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LCUT has higher volatility (43.13%) compared to NVO (8.89%). In terms of maximum drawdown, LCUT dropped -96.52% vs NVO's -74.70%.

LCUT currently has the higher Sharpe Ratio (2.16 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LCUT and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer